Cargando…
Carcinosarcoma of the ovary
We report our experience in the management of patients with carcinosarcoma of the ovary, a rare but aggressive variant of ovarian cancer. Forty patients were treated at a single centre, which is the largest reported series. The median age at diagnosis was 65 years (range 45–86) and the median Karnof...
Autores principales: | Harris, M A, Delap, L M, Sengupta, P S, Wilkinson, P M, Welch, R S, Swindell, R, Shanks, J H, Wilson, G, Slade, R J, Reynolds, K, Jayson, G C |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2376340/ https://www.ncbi.nlm.nih.gov/pubmed/12618869 http://dx.doi.org/10.1038/sj.bjc.6600770 |
Ejemplares similares
-
Requirement for expert histopathological assessment of ovarian cancer and borderline tumours
por: Sengupta, P S, et al.
Publicado: (2000) -
Molecular characterization of carcinosarcomas arising in the uterus and ovaries
por: Brunetti, Marta, et al.
Publicado: (2019) -
Carcinosarcoma of the ovary: a case report and literature review
por: Zheng, Jian, et al.
Publicado: (2023) -
SCOTROC 2B: feasibility of carboplatin followed by docetaxel or docetaxel–irinotecan as first-line therapy for ovarian cancer
por: Clamp, A R, et al.
Publicado: (2006) -
Thrombosis in ovarian cancer: a case control study
por: Metcalf, R L, et al.
Publicado: (2014)